- This event has passed.
Webinar: AI Seminar – Digital Transformation in Biologics Drug Discovery, Challenges and Opportunities
November 15, 4:00 pm to 5:00 pm
Penn State Institute for Computational and Data Sciences is hosting an AI seminar titled “Digital Transformation in Biologics Drug Discovery: Challenges and Opportunities.”
The institute’s Center for Artificial Intelligence Foundations and Scientific Applications will welcome Dr. Maria Wendt, vice president, head of biologics research (U.S.) and global head of digital biologics platform (ML/AI), large molecule research, at Sanofi US.
Registration is required, with a Zoom link to be provided to those who register.
More, better, faster… and now smarter. Sanofi’s large molecule research (LMR) (biologics drug discovery and development organization) is on its journey toward the promise of advanced computation. Sanofi LMR aims to turn innovative science into novel biologic candidates to improve the health of patients. The group sneed to provide a robust engine to discover and deliver innovative biologics to conquer complex diseases via multi-targeting, smart biologics and intelligent drug design. In this talk, Dr. Wendt will provide an introduction to the challenges of discovering and developing large-molecule drugs (biologics) focusing on molecule design and describe the application landscape of AI/ML in this domain. She will provide an overview of Sanofi LMR’s efforts to intensify the use of data and computation in all aspects of biologics discovery and optimization and to transform to next-gen processes driven by ML/AI innovations.
Dr. Maria Wendt is vice president, head of biologics research (U.S.) and global head of digital biologics platform (ML/AI), large molecule research, at Sanofi US, based in Framingham and Cambridge, Mass. She has spent the last 20 years at the interface of computation and biology. At Sanofi, she oversees the internal and collaborative biologics discovery programs for multiple therapeutic areas in the United States, and the platform innovation portfolio including use of ML/AI.
Before Sanofi, she was head of science at Genedata AG in Basel, Switzerland, where she led the creation of Genedata Biologics and Genedata Bioprocess, foundational enterprise informatics platforms in use at most top global biopharma today. In the early part of her career, she focused on omics big data and was one of the leaders of the EU Framework 6 InnoMed Predictive Toxicology consortium. She earned her PhD in chemical engineering from Iowa State University.
For details on this talk, email Liam Jackson, ICDS communications manager, at firstname.lastname@example.org.